Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 31, 2025 • 4:11 PM ET

Date/Time Source News Release
02/10/2025 09:48 PM EST Business Wire Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
01/15/2025 12:07 PM EST Business Wire Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
01/13/2025 07:30 AM EST Business Wire Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025
01/09/2025 05:00 PM EST Business Wire Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
12/10/2024 07:30 AM EST Business Wire Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results
12/04/2024 07:30 AM EST Business Wire Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024
11/18/2024 07:00 AM EST Business Wire Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
11/14/2024 07:30 AM EST Business Wire Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024
11/13/2024 07:30 AM EST Business Wire Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results
10/31/2024 07:30 AM EDT Business Wire Cybin to Participate at the 2024 Milken Institute Future of Health Summit
Page

Additional News

As of March 31, 2025 • 4:11 PM ET

Date/Time Source News Release
03/16/2025 02:46 AM EDT Stock Traders Daily (CYBN) Investment Analysis and Advice
03/13/2025 11:32 AM EDT SeekingAlpha Cybin wins new Buy from Guggenheim: potential to challenge J&J's Spravato cited
03/04/2025 09:35 AM EST Zacks Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
02/27/2025 12:45 PM EST SeekingAlpha Atai: Following The Path That Spravato Laid And Moving Beyond It
02/17/2025 09:55 AM EST Zacks Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet
02/11/2025 02:21 PM EST SeekingAlpha Atai CEO Rao optimistic about psychedelic therapies despite Lykos setback
02/11/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Reports Q3 Financials, Advances Clinical Programs
02/11/2025 12:36 AM EST SeekingAlpha Cybin reports Q3 results
01/30/2025 09:55 AM EST Zacks Wall Street Analysts Believe Cybin Inc. (CYBN) Could Rally 952.23%: Here's is How to Trade
01/29/2025 03:54 PM EST SeekingAlpha HHS Secretary nominee RFK Jr. faces contentious Senate hearing
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.